{"id":109,"date":"2022-04-29T23:13:04","date_gmt":"2022-04-29T15:13:04","guid":{"rendered":"\/?post_type=about&p=109"},"modified":"2022-07-18T14:51:12","modified_gmt":"2022-07-18T06:51:12","slug":"history","status":"publish","type":"about","link":"https:\/\/www.smartnucl.com\/en\/archives\/about\/history","title":{"rendered":"Milestones"},"content":{"rendered":"<h3>Milestones<\/h3>\n<h5 style=\"text-align: center;\"><\/h5>\n<div id='gallery-1' class='gallery galleryid-109 gallery-columns-8 gallery-size-full'><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img width=\"449\" height=\"308\" src=\"https:\/\/www.smartnucl.com\/en\/wp-content\/uploads\/2022\/04\/logo-2.png\" class=\"attachment-full size-full\" alt=\"2016\" loading=\"lazy\" aria-describedby=\"gallery-1-354\" srcset=\"https:\/\/www.smartnucl.com\/en\/wp-content\/uploads\/2022\/04\/logo-2.png 449w, https:\/\/www.smartnucl.com\/en\/wp-content\/uploads\/2022\/04\/logo-2-300x206.png 300w\" sizes=\"(max-width: 449px) 100vw, 449px\" \/>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-354'>\n\t\t\t\tSmart Nuclide was created in Suzhou Industrial Park, \nreceived seed investment\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img width=\"449\" height=\"308\" src=\"https:\/\/www.smartnucl.com\/en\/wp-content\/uploads\/2022\/04\/\u878d\u8d441-1.png\" class=\"attachment-full size-full\" alt=\"2017\" loading=\"lazy\" aria-describedby=\"gallery-1-351\" srcset=\"https:\/\/www.smartnucl.com\/en\/wp-content\/uploads\/2022\/04\/\u878d\u8d441-1.png 449w, https:\/\/www.smartnucl.com\/en\/wp-content\/uploads\/2022\/04\/\u878d\u8d441-1-300x206.png 300w\" sizes=\"(max-width: 449px) 100vw, 449px\" \/>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-351'>\n\t\t\t\tSmart Nuclide announces the Completion of pre-Series A funding\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img width=\"449\" height=\"308\" src=\"https:\/\/www.smartnucl.com\/en\/wp-content\/uploads\/2022\/04\/I\u671f.png\" class=\"attachment-full size-full\" alt=\"2018\" loading=\"lazy\" aria-describedby=\"gallery-1-352\" srcset=\"https:\/\/www.smartnucl.com\/en\/wp-content\/uploads\/2022\/04\/I\u671f.png 449w, https:\/\/www.smartnucl.com\/en\/wp-content\/uploads\/2022\/04\/I\u671f-300x206.png 300w\" sizes=\"(max-width: 449px) 100vw, 449px\" \/>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-352'>\n\t\t\t\tThe first rhTSh product (SNA001) in China receives IND approval from NMPA, Smart Nuclide launches phase I\/II clinical trial in Zhongshan Hospital\n\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img width=\"449\" height=\"308\" src=\"https:\/\/www.smartnucl.com\/en\/wp-content\/uploads\/2022\/04\/\u4e09\u671f\u542f\u52a8.png\" class=\"attachment-full size-full\" alt=\"2019\" loading=\"lazy\" aria-describedby=\"gallery-1-350\" srcset=\"https:\/\/www.smartnucl.com\/en\/wp-content\/uploads\/2022\/04\/\u4e09\u671f\u542f\u52a8.png 449w, https:\/\/www.smartnucl.com\/en\/wp-content\/uploads\/2022\/04\/\u4e09\u671f\u542f\u52a8-300x206.png 300w\" sizes=\"(max-width: 449px) 100vw, 449px\" \/>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-350'>\n\t\t\t\tSmart Nuclide launches Phase III clinical trial of SNA001, completes preliminary preparations for Investigational New Drug Application of SNA002\n\n\n\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img width=\"449\" height=\"308\" src=\"https:\/\/www.smartnucl.com\/en\/wp-content\/uploads\/2022\/04\/\u5408\u6210-1.png\" class=\"attachment-full size-full\" alt=\"2020\" loading=\"lazy\" aria-describedby=\"gallery-1-348\" srcset=\"https:\/\/www.smartnucl.com\/en\/wp-content\/uploads\/2022\/04\/\u5408\u6210-1.png 449w, https:\/\/www.smartnucl.com\/en\/wp-content\/uploads\/2022\/04\/\u5408\u6210-1-300x206.png 300w\" sizes=\"(max-width: 449px) 100vw, 449px\" \/>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-348'>\n\t\t\t\tSmart Nuclide raises nearly CNY 100.0 M in Series B round, granted the \u201cNational Science and Technology Major Project for Novel Drug Development Unit\u201d. Smart Nuclide announces the establishment of Radiopharmaceutical Collaborative Innovation Center with Soochow University\n\n\n\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img width=\"449\" height=\"308\" src=\"https:\/\/www.smartnucl.com\/en\/wp-content\/uploads\/2022\/04\/\u5b8c\u6210III\u671f.png\" class=\"attachment-full size-full\" alt=\"2021\" loading=\"lazy\" aria-describedby=\"gallery-1-353\" srcset=\"https:\/\/www.smartnucl.com\/en\/wp-content\/uploads\/2022\/04\/\u5b8c\u6210III\u671f.png 449w, https:\/\/www.smartnucl.com\/en\/wp-content\/uploads\/2022\/04\/\u5b8c\u6210III\u671f-300x206.png 300w\" sizes=\"(max-width: 449px) 100vw, 449px\" \/>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-353'>\n\t\t\t\tSmart Nuclide raises nearly CNY 100.0 M in Series C round, SNA001 completes phase III clinical trial. Smart Nuclide announces the plan to start Investigational New Drug Application (IND) file of SNA002 in the U.S. and China, SNA006 starts investigator-initiated trials (IIT)\n\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img width=\"449\" height=\"308\" src=\"https:\/\/www.smartnucl.com\/en\/wp-content\/uploads\/2022\/04\/\u65b0\u5927\u697c.png\" class=\"attachment-full size-full\" alt=\"2022\" loading=\"lazy\" aria-describedby=\"gallery-1-349\" srcset=\"https:\/\/www.smartnucl.com\/en\/wp-content\/uploads\/2022\/04\/\u65b0\u5927\u697c.png 449w, https:\/\/www.smartnucl.com\/en\/wp-content\/uploads\/2022\/04\/\u65b0\u5927\u697c-300x206.png 300w\" sizes=\"(max-width: 449px) 100vw, 449px\" \/>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-349'>\n\t\t\t\tSNA001 files the Biologics License Application (BLA) to Center For Drug Evaluation (CDE), SNA002 has started investigator-initiated trials (IIT), received U.S. FDA Clearance and CDE of Clinical Trial, starting the Global clinical trial.\n\t\t\t\t<\/figcaption><\/figure>\n\t\t<\/div>\n\n","protected":false},"excerpt":{"rendered":"<p>Milestones<\/p>\n","protected":false},"featured_media":79,"menu_order":0,"template":"","categories":[],"tags":[],"_links":{"self":[{"href":"https:\/\/www.smartnucl.com\/en\/wp-json\/wp\/v2\/about\/109"}],"collection":[{"href":"https:\/\/www.smartnucl.com\/en\/wp-json\/wp\/v2\/about"}],"about":[{"href":"https:\/\/www.smartnucl.com\/en\/wp-json\/wp\/v2\/types\/about"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.smartnucl.com\/en\/wp-json\/wp\/v2\/media\/79"}],"wp:attachment":[{"href":"https:\/\/www.smartnucl.com\/en\/wp-json\/wp\/v2\/media?parent=109"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.smartnucl.com\/en\/wp-json\/wp\/v2\/categories?post=109"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.smartnucl.com\/en\/wp-json\/wp\/v2\/tags?post=109"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}